高级检索
    吴一龙, 廖美琳, 周清华, 蒋国樑, 陆舜, 王洁, 程颖, 张力, 张绪超, 刘晓晴, 韩宝惠, 钟文昭, 周彩存, 宋勇, 马胜林, 王长利, 杨学宁, 毛伟敏, 王俊, 许林, 陈海泉, 傅小龙, 冯继锋, 宋启斌, 于世英, 伍钢, 朱广迎, 陈公琰, 熊建萍, 杨衿记, 王建军, 陈克能, 申屠阳, 张沂平, 胡艳萍, 于丁, 宋恕平, 胡成平, 宋向群, 常建华, 陈刚, 张贺龙, 李伟雄, 王震. 非小细胞肺癌小分子靶向药物耐药处理共识[J]. 循证医学, 2013, 13(2): 65-69. DOI: 10.3969/j.issn.1671-5144.2013.02.001
    引用本文: 吴一龙, 廖美琳, 周清华, 蒋国樑, 陆舜, 王洁, 程颖, 张力, 张绪超, 刘晓晴, 韩宝惠, 钟文昭, 周彩存, 宋勇, 马胜林, 王长利, 杨学宁, 毛伟敏, 王俊, 许林, 陈海泉, 傅小龙, 冯继锋, 宋启斌, 于世英, 伍钢, 朱广迎, 陈公琰, 熊建萍, 杨衿记, 王建军, 陈克能, 申屠阳, 张沂平, 胡艳萍, 于丁, 宋恕平, 胡成平, 宋向群, 常建华, 陈刚, 张贺龙, 李伟雄, 王震. 非小细胞肺癌小分子靶向药物耐药处理共识[J]. 循证医学, 2013, 13(2): 65-69. DOI: 10.3969/j.issn.1671-5144.2013.02.001
    shu
    WU Yi-long, LIAO Mei-lin, ZHOU Qing-hua, JIANG Guo-liang, LU Shun, WANG Jie, CHENG Ying, ZHANG Li, ZHANG Xu-chao, LIU Xiao-qing, HAN Bao-hui, ZHONG Wen-zhao, ZHOU Cai-cun, SONG Yong, MA Sheng-lin, WANG Chang-li, YANG Xue-ning, MAO Wei-min, WANG Jun, XU Lin, CHEN Hai-quan, FU Xiao-long, FENG Ji-feng, SONG Qi-bin, YU Shi-ying, WU Gang, ZHU Guang-ying, CHEN Gong-yan, XIONG Jian-ping, YANG Jin-ji, WANG Jian-jun, CHEN Ke-neng, SHEN Tu-yang, ZHANG Yi-ping, HU Yan-ping, YU Ding, SONG Shu-ping, HU Cheng-ping, SONG Xiang-qun, CHANG Jian-hua, CHEN Gang, ZHANG He-long, LI Wei-xiong, WANG Zhen. The Consensus of Non-Small Cell Lung Cancer with Small Molecular Targeted Drug Resistance[J]. Journal of Evidence-Based Medicine, 2013, 13(2): 65-69. DOI: 10.3969/j.issn.1671-5144.2013.02.001
    Citation: WU Yi-long, LIAO Mei-lin, ZHOU Qing-hua, JIANG Guo-liang, LU Shun, WANG Jie, CHENG Ying, ZHANG Li, ZHANG Xu-chao, LIU Xiao-qing, HAN Bao-hui, ZHONG Wen-zhao, ZHOU Cai-cun, SONG Yong, MA Sheng-lin, WANG Chang-li, YANG Xue-ning, MAO Wei-min, WANG Jun, XU Lin, CHEN Hai-quan, FU Xiao-long, FENG Ji-feng, SONG Qi-bin, YU Shi-ying, WU Gang, ZHU Guang-ying, CHEN Gong-yan, XIONG Jian-ping, YANG Jin-ji, WANG Jian-jun, CHEN Ke-neng, SHEN Tu-yang, ZHANG Yi-ping, HU Yan-ping, YU Ding, SONG Shu-ping, HU Cheng-ping, SONG Xiang-qun, CHANG Jian-hua, CHEN Gang, ZHANG He-long, LI Wei-xiong, WANG Zhen. The Consensus of Non-Small Cell Lung Cancer with Small Molecular Targeted Drug Resistance[J]. Journal of Evidence-Based Medicine, 2013, 13(2): 65-69. DOI: 10.3969/j.issn.1671-5144.2013.02.001
    shu

    非小细胞肺癌小分子靶向药物耐药处理共识

    The Consensus of Non-Small Cell Lung Cancer with Small Molecular Targeted Drug Resistance

      摘要
    • 摘要: 2013年3月8-9日,中国抗癌协会肺癌专业委员会和中国抗癌协会临床肿瘤学专业委员会（Chinese Society of Clinical Oncology,CSCO）联合主办了第十届“中国肺癌高峰共识会”,来自全国的600多位专家,讨论了肺癌小分子靶向药物的耐药机制和应对策略。专家们认为,小分子靶向药物是肺癌治疗史上的里程碑事件,但其无可避免的耐药现象,成为进一步提高靶向药物疗效的瓶颈。深入了解小分子靶向药物的耐药机制,根据耐药机制和临床规律制定相应的应对策略,是指导小分子靶向药物合理应用的当务之急。经过详细的讨论和思辨,最终形成了非小细胞肺癌（non-small cell lung cancer,NSCLC）小分子靶向药物耐药处理共识。

       

      • HTML全文
      • 参考文献(23)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回